Transactions
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2018-01-23 | Avanza Bank Holding AB | Birgitta Torstenius Hagenfeldt | Ekonomi/finanschef, Vice VD | Disposal | 225 | 432 | SEK | 97 200 | 2018-01-22 |
| 2018-01-23 | Avanza Bank Holding AB | Birgitta Torstenius Hagenfeldt | Ekonomi/finanschef, Vice VD | Disposal | 500 | 430,4 | SEK | 215 200 | 2018-01-22 |
| 2018-01-23 | Avanza Bank Holding AB | Birgitta Torstenius Hagenfeldt | Ekonomi/finanschef, Vice VD | Disposal | 140 | 431,4 | SEK | 60 396 | 2018-01-22 |
| 2018-01-23 | Avanza Bank Holding AB | Birgitta Torstenius Hagenfeldt | Ekonomi/finanschef, Vice VD | Disposal | 135 | 433 | SEK | 58 455 | 2018-01-22 |
| 2018-01-23 | Avanza Bank Holding AB | Birgitta Torstenius Hagenfeldt | Ekonomi/finanschef, Vice VD | Disposal | 1 019 | 434,4 | SEK | 442 653,6 | 2018-01-22 |
| 2018-01-23 | Avanza Bank Holding AB | Birgitta Torstenius Hagenfeldt | Ekonomi/finanschef, Vice VD | Disposal | 151 | 434,6 | SEK | 65 624,6 | 2018-01-22 |
| 2018-01-23 | Avanza Bank Holding AB | Birgitta Torstenius Hagenfeldt | Ekonomi/finanschef, Vice VD | Disposal | 230 | 432,2 | SEK | 99 406 | 2018-01-22 |
| 2018-01-23 | ChromoGenics AB | Micael Hamberg | COO | Acquisition | 50 000 | 1,75 | SEK | 87 500 | 2018-01-21 |
| 2018-01-23 | ChromoGenics AB | Micael Hamberg | COO | Acquisition | 20 000 | 1,75 | SEK | 35 000 | 2018-01-21 |
| 2018-01-23 | Isofol Medical AB (publ) | Karin Ganlöv | Chief Medical Officer | Subscription | 13 664 | 17 | SEK | 232 288 | 2018-01-18 |
| 2018-01-23 | Isofol Medical AB (publ) | Anders Gunnar Rabbe | VD | Subscription | 34 159 | 17 | SEK | 580 703 | 2018-01-18 |
| 2018-01-23 | Zinzino AB | Dag Bergheim Pettersen | VD/CEO | Acquisition | 5 000 | 9 | SEK | 45 000 | 2018-01-21 |
| 2018-01-23 | Isofol Medical AB (publ) | Anders Gunnar Rabbe | VD | Subscription | 34 160 | 17 | SEK | 580 720 | 2018-01-18 |
| 2018-01-23 | EnergyO Solutions Invest AB | Ulf-Henrik Svensson | VD | Disposal | 62 394 | 14,44 | SEK | 900 969,36 | 2018-01-17 |
| 2018-01-23 | Xbrane Biopharma AB | Siavash Bashiri | COO & Head of Biosimilars | Acquisition | 289 | 79,6 | SEK | 23 004,4 | 2018-01-22 |
| 2018-01-23 | Xbrane Biopharma AB | Siavash Bashiri | COO & Head of Biosimilars | Acquisition | 275 | 79,5 | SEK | 21 862,5 | 2018-01-22 |
| 2018-01-23 | Isofol Medical AB (publ) | Bengt Gustaf Gustafsson | Styrelseledamot/suppleant | Subscription | 50 000 | 17 | SEK | 850 000 | 2018-01-18 |
| 2018-01-23 | Chromogenics AB | Erik Anders Brännström | Styrelseledamot/suppleant | Acquisition | 74 998 | 1,75 | SEK | 131 246,5 | 2018-01-21 |
| 2018-01-23 | Polyplank | Leif Jilkén | Styrelseledamot/suppleant | Acquisition | 1 500 | 0,16 | SEK | 240 | 2018-01-18 |
| 2018-01-23 | Polyplank | Leif Jilkén | Styrelseledamot/suppleant | Acquisition | 12 643 | 0,17 | SEK | 2 149,31 | 2018-01-21 |